Islet Transplants


By: Elka Karl

A gene therapy technique could help islet transplants, but current anti-rejection drug therapy may hurt transplanted cells.

A University of Pittsburgh study found that using a growth factor in islets could greatly reduce the number of islets needed for transplants to reverse type 1 diabetes.

However, the study also indicates that current triple-drug therapy used in anti-rejection therapy after islet transplants can harm transplanted pancreatic rat islets. It may also induce diabetes in rats as shown in the control group receiving only the anti-rejection therapy.

“This study suggests that the current anti-rejection regimen might need to be further optimized or changed,” says senior study author Andrew Stewart, MD.

-Endocrinology, February 2004



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.